phase 2 results due very soon, page-7

Hiya,

CMQ just ran because brokers just decided to run it. It has no real business yet, just blue sky. 20c issue price. When you get companies that applaud other company's announcments like the recent mcdonalds one where they said well done to mcdonalds for removing AB in foods without actually having a contract with them I'd be a bit worried.

So its like VNA in the past, FLT, ALL, CSL and others with enormous p:e's, it just because a bulk of people all got into them, eventually someone will be the last one holding when the game ends.

ie. it is difficult to pick the next CMQ since it is what the brokers decide to all stack into. I'm not sure if EPT is good enough, since there is not much of it being vague in what they do, its pretty clear. I think though, the main card is if they link up with a major pharm company, though they may even be taken over, $1 + is not impossible.

I think EPT has very good potential and shall accumulate on any future weaknesses. EPT has a good product that will work I believe and also is cheap at current levels. Like MDM which also has a small market cap risk is minimized compared to the current level of CMQ which is not sustainable once it begins to be tested. CMQ is worth something, but its not one of the top 200 companies in this country, the business I work for makes more profit than CMQ, maybe it should be in the top 200 :P